...
首页> 外文期刊>Quality of life research: An international journal of quality of life aspects of treatment, care and rehabilitation >The health-related quality of life burden of co-morbid cardiovascular disease and major depressive disorder in Australia: Findings from a population-based, cross-sectional study
【24h】

The health-related quality of life burden of co-morbid cardiovascular disease and major depressive disorder in Australia: Findings from a population-based, cross-sectional study

机译:澳大利亚合并症心血管疾病和重度抑郁症的健康相关生活质量负担:基于人群的横断面研究的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Health-related quality of life (HRQOL) can be significantly impaired by the presence of chronic conditions such as cardiovascular disease (CVD) and major depressive disorder (MDD). The aim of this paper was to (1) identify differences in HRQOL between individuals with CVD, MDD, or both, compared to a healthy reference group, (2) establish whether the influence of co-morbid MDD and CVD on HRQOL is additive or synergistic and (3) determine the way in which depression severity interacts with CVD to influence overall HRQOL. Methods: Population-based data from the 2007 Australian National Survey of Mental Health and Well-being (NSMHWB) (n = 8841) were used to compare HRQOL of individuals with MDD and CVD, MDD but not CVD, CVD but not MDD, with a healthy reference group. HRQOL was measured using the Assessment of Quality of Life (AQOL). MDD was identified using the Composite International Diagnostic Interview (CIDI 3.0). Results: Of all four groups, individuals with co-morbid CVD and depression reported the greatest deficits in AQOL utility scores (Coef: -0.32, 95% CI: -0.40, -0.23), after adjusting for covariates. Those with MDD only (Coef: -0.27, 95% CI: -0.30, -0.24) and CVD only (Coef: -0.08, 95% CI: -0.11, -0.05) also reported reduced AQOL utility scores. Second, the influence of MDD and CVD on HRQOL was shown to be additive, rather than synergistic. Third, a significant dose-response relationship was observed between depression severity and HRQOL. However, CVD and depression severity appeared to act independently of each other in impacting HRQOL. Conclusions: HRQOL is greatly impaired in individuals with co-morbid MDD and CVD; these conditions appear to influence HRQOL in an additive fashion. HRQOL alters with depression severity, therefore treating depression and improving HRQOL is of clinical importance. ? 2012 The Author(s).
机译:目的:慢性疾病(例如心血管疾病(CVD)和严重抑郁症(MDD))的存在会严重损害健康相关的生活质量(HRQOL)。本文的目的是(1)确定健康人与健康对照组相比,CVD,MDD或两者之间的HRQOL差异;(2)确定MDD和CVD对HRQOL的影响是相加还是相加。 (3)确定抑郁症严重程度与CVD相互作用以影响整体HRQOL的方式。方法:使用2007年澳大利亚全国心理健康与幸福调查(NSMHWB)(n = 8841)的基于人群的数据,比较MDD和CVD,MDD但不CVD,CVD但不MDD的人的HRQOL。一个健康的参考人群。 HRQOL使用生活质量评估(AQOL)进行测量。 MDD是通过《综合国际诊断访谈》(CIDI 3.0)确定的。结果:在校正了协变量之后,在所有四个组中,患有合并症的CVD和抑郁症的人报告了AQOL效用评分的最大缺陷(Coef:-0.32,95%CI:-0.40,-0.23)。仅使用MDD(Coef:-0.27,95%CI:-0.30,-0.24)和使用CVD(Coef:-0.08,95%CI:-0.11,-0.05)的患者也报告了AQOL实用评分降低。其次,MDD和CVD对HRQOL的影响被证明是累加的,而不是协同的。第三,观察到抑郁症严重程度与HRQOL之间存在显着的剂量反应关系。但是,CVD和抑郁症严重程度似乎在影响HRQOL方面彼此独立。结论:合并MDD和CVD的患者HRQOL显着受损。这些条件似乎以累加的方式影响HRQOL。 HRQOL随着抑郁的严重程度而改变,因此治疗抑郁和改善HRQOL具有重要的临床意义。 ? 2012作者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号